A flexible data architecture to automate collection of (near) real-time methane sensor data at commercial dairy farms

To reduce methane emissions from the animal production domain, a large intensive research programme has been started in 2018 by the Dutch Ministry of Agriculture, Nature and Food. Part of this programme involves continuous monitoring of methane, by means of sensor measurements, both at the barn and ..

Partial stem resistance in Brassica napus to highly aggressive and genetically diverse Sclerotinia sclerotiorum isolates from Australia

Sclerotinia sclerotiorum is a fungal pathogen that causes stem rot in oilseed rape (Brassica napus). Previously, B. napus accessions with partial stem resistance to a Canadian S. sclerotiorum isolate (#321) were identified using a stem test in which flowering plants were inoculated with mycelium plugs. The present study examined the partial stem resistance of four of these accessions, PAK54, PAK93, DC21 and K22, following inoculation with Australian isolates. Mycelial compatibility groups and intergenic spacer (IGS) region haplotypes were identified among 71 isolates from Australian oilseed rape and lupin fields. Eleven genetically diverse isolates showed differences in aggressiveness when inoculated onto nine oilseed rape varieties and one Chinese accession. Isolates CU8.24, CU10.17 and CU11.19 were selected based on genetic diversity, growth rate in vitro and high aggressiveness in the initial screen and subsequently inoculated onto the four B. napus accessions. These accessions developed significantly smaller lesions compared with the susceptible control varieties (‘AV Garnet’ and ‘Westar’), with the average frequency of soft and collapsed lesions being less than 20% in PAK54, DC21 and K22, 29% in PAK93 and greater than 88% in the susceptible controls. Microscopic examination revealed that hyphae were typically confined to the stem cortex in the smallest lesions, but could be found in the stem pith in larger lesions. These results show that B. napus accessions PAK54, PAK93, DC21 and K22 can be used in Australia for development of varieties with partial stem resistance to S. sclerotiorum

3D MHD Modeling of the Gaseous Structure of the Galaxy: Setup and Initial Results

We show the initial results of our 3D MHD simulations of the flow of the Galactic atmosphere as it responds to a spiral perturbation in the potential. In our standard case, as the gas approaches the arm, there is a downward converging flow that terminates in a complex of shocks just ahead of the midplane density peak. The density maximum slants forward at high z, preceeded by a similarly leaning shock. The latter diverts the flow upward and over the arm, as in a hydraulic jump. Behind the gaseous arm, the flow falls again, generating further secondary shocks as it approaches the lower z material. Structures similar to the high z part of the gaseous arms are found in the interarm region of our two-armed case, while broken arms and low column density bridges are present in the four-armed case. We present three examples of what can be learned from these models.Comment: 33 pages, 17 figures. Accepted for publication in Apj. Better quality images in http://www.journals.uchicago.edu/ApJ/journal/preprints/ApJ55782.preprint.pd

Rich interaction and feedback supported mammographic training: A trial of an augmented reality approach

The conventional ‘keyboard and workstation’ approach allows complex medical image presentation and manipulation during mammographic interpretation. Nevertheless, providing rich interaction and feedback in real time for navigational training or computer assisted detection of disease remains a challenge. Through computer vision and state of the art AR (Augmented Reality) technique, this study proposes an ‘AR mammographic workstation’ approach which could support workstation-independent rich interaction and real-time feedback. This flexible AR approach explores the feasibility of facilitating various mammographic training scenes via AR as well as its limitations

Maintenance ketamine treatment for depression:a systematic review of efficacy, safety, and tolerability

Ketamine has rapid yet often transient antidepressant effects in patients with treatment-resistant depression. Different strategies have been proposed to prolong these effects. Maintenance ketamine treatment appears promising, but little is known about its efficacy, safety, and tolerability in depression. We searched Pubmed, Embase, and the Cochrane Library and identified three randomised controlled trials, eight open-label trials, and 30 case series and reports on maintenance ketamine treatment. We found intravenous, intranasal, oral, and possibly intramuscular and subcutaneous maintenance ketamine treatment to be effective in sustaining antidepressant effect in treatment-resistant depression. Tachyphylaxis, cognitive impairment, addiction, and serious renal and urinary problems seem uncommon. Despite the methodological limitations, we conclude that from a clinical view, maintenance ketamine treatment seems to be of therapeutic potential. We recommend both controlled and naturalistic studies with long-term follow-up and sufficient power to determine the position of maintenance ketamine treatment within routine clinical practice.</p

Is ketamine an appropriate alternative to ECT for patients with treatment resistant depression? A systematic review:A systematic review

OBJECTIVE: Ketamine has repeatedly shown to have rapid and robust antidepressant effects in patients with treatment resistant depression (TRD). An important question is whether ketamine is as effective and safe as the current gold standard electroconvulsive therapy (ECT). METHODS: The literature was searched for trials comparing ketamine treatment with ECT for depression in the Pubmed/MEDLINE database and Cochrane Trials Library. RESULTS: A total of 137 manuscripts were identified, 6 articles were included in this review. Overall quality of the included studies was diverse with relevant risk of bias for some of the studies. Results suggest that ketamine treatment might give faster but perhaps less durable antidepressant effects. Side effects differed from ECT, in particular less cognitive impairment was apparent in ketamine treatment. LIMITATIONS: The included studies have limited sample sizes, use different treatment protocols and in most trials, longer term follow up is lacking. Furthermore, allocation bias appears likely in the non-randomized trials. CONCLUSIONS: Current available literature does not yet provide convincing evidence to consider ketamine as an equally effective treatment alternative to ECT in patients with TRD. There are indications for a more favourable short term cognitive side effect profile after ketamine treatment. Methodologically well-designed studies with larger sample sizes and longer follow up duration are warranted

Coverage of harm reduction services and HIV infection: A multilevel analysis of five Chinese cities

__Background:__ Since 2003, a harm reduction program for injecting drug users has been rolled out countrywide in China. It entails services for condom promotion, a needle and syringe program (NSP), and methadone maintenance treatment (MMT). However, it remains unknown if and to what extent the coverage of these services at city level is related to a reduced risk of HIV infection among drug users. __Methods:__ We wished to quantify the extent to which city-level characteristics (such as NSP and MMT service coverage) and individual-level determinants (e.g., self-reported exposure to NSP and MMT services, knowledge, motivation, and skills) were associated with the risk of HIV infection among drug users. In 2006, we conducted an integrated serological and behavioral survey among drug users in five cities of Yunnan Province, China (N = 685), constructing a multilevel logistic regression model with drug users clustered within these cities. __Results:__ Drug users who reported having received NSP or MMT services were about 50% less likely to be infected with HIV than those who reported not having received them (OR 0.45, 95% CI, 0.26-0.83 for NSP and 0.48, 95% CI, 0.31-0.73 for MMT). Despite a between-city variation of HIV infection risk (ICC 0.24, 95% CI 0.08-0.54), none of the city-level factors could explain this difference. Individual-level determinants such as perceived risk of infection and use of condoms were not associated with HIV infection. __Conclusions:__ Although people who had used NSP or MMT services were less likely to be HIV infected, this study found no relationship between city-level coverage of HIV prevention programs and variations in HIV infection between cities. This may have been due to the low number of cities in the analysis. Future research should include the analysis of data from a larger number of cities, which are collected widely in China through integrated behavioral and serological surveys

The antidepressant effect and safety of non-intranasal esketamine:A systematic review

BACKGROUND: The introduction of esketamine into the field of psychiatry comes on the heels of excitement from studies on racemic ketamine. While the intranasal route has been the most studied to date, other modes of administration of esketamine may also be of interest in the management of depression. AIMS: To systematically review the literature on non-intranasal esketamine for depression in terms of its antidepressant effect and safety. METHODS: We searched PubMed, Embase, the Cochrane Library, and Google Scholar from inception up to February 2021. Search terms included a combination of Medical Subject Headings and text words indicative of esketamine and depression. We selected both controlled and uncontrolled studies examining non-intranasal esketamine for the treatment of depression. RESULTS: We identified four randomized controlled trials (RCTs) on intravenous esketamine and 15 open-label studies on intravenous (n = 80), subcutaneous (n = 73), and oral (n = 5) esketamine. We found intravenous, subcutaneous, and possibly oral administration of esketamine to be effective in reducing depressive symptoms in most patients with major depressive disorder, bipolar depression, and (severe) treatment-resistant depression. Clinical response to repeated administration of esketamine persisted over the course of treatment. Esketamine was well tolerated by most patients, but open-label data indicate marked psychotomimetic symptoms in exceptional cases. The overall quality of the controlled studies was considered high, the overall quality of the uncontrolled studies low to moderate. CONCLUSIONS: Intravenous, subcutaneous, and possibly oral esketamine may offer an effective and safe addition to the depression treatment armamentarium. However, as most included studies lacked a control group and had small sample sizes, the quality of our results is limited. Different types and formulations of ketamine remain to be compared directly

Pharmacodynamic Interactions Between Ketamine and Psychiatric Medications Used in the Treatment of Depression:A Systematic Review

Background The use of ketamine for depression has increased rapidly in the past decades. Ketamine is often prescribed as an add-on to other drugs used in psychiatric patients, but clear information on drug-drug interactions is lacking. With this review, we aim to provide an overview of the pharmacodynamic interactions between ketamine and mood stabilizers, benzodiazepines, monoamine oxidase-inhibitors, antipsychotics, and psychostimulants. Methods MEDLINE and Web of Science were searched. Results Twenty-four studies were included. For lithium, no significant interactions with ketamine were reported. Two out of 5 studies on lamotrigine indicated that the effects of ketamine were attenuated. Benzodiazepines were repeatedly shown to reduce the duration of ketamine's antidepressant effect. For the monoamine oxidase-inhibitor tranylcypromine, case reports showed no relevant changes in vital signs during concurrent S-ketamine use. One paper indicated an interaction between ketamine and haloperidol, 2 other studies did not. Four papers investigated risperidone, including 3 neuroimaging studies showing an attenuating effect of risperidone on ketamine-induced brain perfusion changes. Clozapine significantly blunted ketamine-induced positive symptoms in patients with schizophrenia but not in healthy participants. One paper reported no effect of olanzapine on ketamine's acute psychotomimetic effects. Conclusion Current literature shows that benzodiazepines and probably lamotrigine reduce ketamine's treatment outcome, which should be taken into account when considering ketamine treatment. There is evidence for an interaction between ketamine and clozapine, haloperidol, and risperidone. Due to small sample sizes, different subject groups and various outcome parameters, the evidence is of low quality. More studies are needed to provide insight into pharmacodynamic interactions with ketamine

CO(1-0), CO(2-1) and Neutral Gas in NGC 6946: Molecular Gas in a Late-Type, Gas Rich, Spiral Galaxy

We present "On The Fly" maps of the CO(1-0) and CO(2-1) emission covering a 10' X 10' region of the NGC 6946. Using our CO maps and archival VLA HI observations we create a total gas surface density map, Sigma_gas, for NGC 6946. The predominantly molecular inner gas disk transitions smoothly into an atomic outer gas disk, with equivalent atomic and molecular gas surface densities at R = 3.5' (6 kpc). We estimate that the total H2 mass is 3 X 10^9 Mo, roughly 1/3 of the interstellar hydrogen gas mass, and about 2% of the dynamical mass of the galaxy at our assumed distance of 6 Mpc. The value of the CO(2-1)/CO(1-0) line ratio ranges from 0.35 to 2; 50% of the map is covered by very high ratio, >1, gas. The very high ratios are predominantly from interarm regions and appear to indicate the presence of wide-spread optically thin gas. Star formation tracers are better correlated with the total neutral gas disk than with the molecular gas by itself implying SFR is proportional to Sigma_gas. Using the 100 FIR and 21 cm continuum from NGC 6946 as star formation tracers, we arrive at a gas consumption timescale of 2.8 Gyr, which is relatively uniform across the disk. The high star formation rate at the nucleus appears to be due to a large accumulation of molecular gas rather than a large increase in the star formation efficiency. The mid-plane gas pressure in the outer (R > 10 kpc) HI arms of NGC 6946 is close to the value at the radial limit (10 kpc) of our observed CO disk. If the mid-plane gas pressure is a factor for the formation of molecular clouds, these outer HI gas arms should contain molecular gas which we do not see because they are beyond our detection limit